New Light-Based monitor could help protect newborn brains

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

TERM/NEAR-TERM GROUP INCLUSION CRITERIA: 1. Infants born at greater than or equal to 34 weeks gestational age undergoing therapeutic hypothermia as an intervention for moderate to severe neonatal encephalopathy. These infants will meet the following criteria for treatment: * Evidence of intrapartum asphyxia as defined by ANY of the following features: Apgar score of 5 or less at 10 minutes after birth; ongoing need for endotracheal or mask ventilation at 10 minutes after birth; pH \<7.00 in cord or baby sample within 60 minutes of birth; base deficit greater than or equal to 16mmol/L in cord or baby sample within 60 minutes of birth. * Moderate or severe encephalopathy, including ALL of the following criteria OR altered consciousness plus seizures: altered consciousness (reduced or absent response to stimulation); abnormal primitive reflexes (weak or absent suck or Moro response); abnormal tone (hypotonia, flaccid). 2. Signed parental consent form. EXCLUSION CRITERIA: 1. Lack of signed parental consent form and/or parental decision not to participate. 2. Infants with life threatening congenital malformations. 3. Infants with encephalopathy caused by differing pathology to hypoxia-ischaemia. PRETERM GROUP INCLUSION CRITERIA: 1. Infants born at less than 28 weeks completed gestation. 2. Signed informed parental consent form for each specific section/sub-study. 3. For skin-to-skin sub-study: considered by responsible clinical team to be eligible for skin-to-skin care as per usual local practice. 4. For BPD sub-study: infants born at less than 28 weeks gestational age surviving to 36 weeks corrected gestational age. Infants with and without a diagnosis of BPD will be recruited to allow for comparison of cerebral oxygenation between these groups. EXCLUSION CRITERIA: 1. Lack of signed parental consent form and/or parental decision not to participate. 2. Decision not to provide active (survival focussed) neonatal management. 3. Infants with life threatening congenital malformation. 4. Infants in whom there is a particularly high level of concerns regarding skin fragility or loss of skin integrity resulting in application of NIRS probe being contraindicated. 5. Infants who are transferred back to local centres will be excluded from the BPD sub-study if transferred back to local centre prior to 36 weeks corrected gestational age and from follow-up data collection due to difficulties achieving acquisition of full data set for babies followed up in health boards outwith NHS Lothian.